Physicochemical changes of urine environment on propionhydroxamic acid therapy.
Bruno
M
M
Department of Nephrology, Mauriziano Umberto I Hospital, Turin, Italy.
Marangella
M
M
Tricerri
A
A
Martini
C
C
Linari
F
F
D000328:Adult; D000641:Ammonia / Q000652:urine; D001424:Bacterial Infections / Q000150:complications; D002951:Citrates / Q000652:urine; D005260:Female; D006801:Humans; D006863:Hydrogen-Ion Concentration; D006877:Hydroxamic Acids / Q000627:therapeutic use*; D008274:Magnesium / Q000652:urine; D017616:Magnesium Compounds; D008297:Male; D008875:Middle Aged; D010710:Phosphates / Q000652:urine; D000069877:Struvite; D014510:Urease / Q000037:antagonists & inhibitors*; D014545:Urinary Calculi / Q000188:drug therapy* / Q000209:etiology / Q000652:urine
D002951:Citrates; D006877:Hydroxamic Acids; D017616:Magnesium Compounds; D010710:Phosphates; D000641:Ammonia; C036612:propionohydroxamic acid; D000069877:Struvite; D014510:Urease; D008274:Magnesium